Other Information and Data Clause Samples
The "Other Information and Data" clause defines the parties' obligations regarding the provision, use, and handling of information or data not specifically addressed elsewhere in the agreement. Typically, this clause outlines what types of additional data must be shared, the format or timing for such disclosures, and any restrictions or responsibilities related to its use. Its core function is to ensure that all relevant information necessary for the contract's performance is exchanged transparently, thereby preventing misunderstandings and supporting effective collaboration between the parties.
Other Information and Data. In accordance with the following provisions, each Party shall provide to the other Party complete and accurate copies of all documentation containing Supporting Data and Adverse Experience Data relating to any Product which is prepared or acquired by such Party or any of its respective permitted sublicensees during the term of this Agreement:
(a) Copies of Supporting Data in English shall be forwarded by express mail or other equivalent courier service as soon as practicable after it has been prepared or acquired, but, in any case, Dainippon shall provide a summary in English thereof no later than one hundred twenty (120) days after such preparation or acquisition and the provisions for translation set forth in Section 3.5 shall apply to information provided herein; and
(b) Copies of Adverse Experience Data in English shall be forwarded by facsimile with a duplicate by express mail or other equivalent courier service as quickly as may be necessary to permit the recipient to comply with any applicable legal requirements and in no event later than the earlier of (i) in the case of Serious and Unexpected Adverse Experience Data, fourteen (14) working days after such Adverse Experience Data has been prepared or acquired or (ii) in the case of Adverse Experience Data that is not Serious and Unexpected, the date on which such Adverse Experience Data is provided to any Competent Authority anywhere in the world, or within such other time frame as may be mutually agreed to by the Parties in writing. The Parties shall consult and agree on the form of such reporting of Adverse Experience Data by each Party to the other.
Other Information and Data. Millennium shall also provide Portola with additional material information and data that is necessary or useful for Regulatory Approval or commercialization of Products and that is referenced or summarized in any of the items transferred to Portola pursuant to Section 4.3 for the Products but that is not otherwise transferred to Portola pursuant to this Article 4. Millennium shall also provide Portola with all information regarding adverse events reported in relation to the Products, in a mutually acceptable format. Millennium will use reasonable efforts to cooperate with Portola to advise Portola with respect to questions raised with Portola by Regulatory Authorities regarding Products; provided that Portola shall nevertheless continue to have the primary responsibility to prepare responses and respond to all such questions and inquiries. Portola shall have the right to reference and incorporate such data provided by Millennium pursuant to this Section 4.4 in Portola’s regulatory filings for Products.
Other Information and Data. Each Party shall provide to the other Party complete and accurate copies of all documentation containing Supporting Data, adverse experience data (as defined below) and other data relating to the Products prepared or acquired by such Party or any of its respective Affiliates or sublicensees during the term of this Agreement. Copies of Supporting Data shall be forwarded within 30 days after prepared or acquired. Copies of adverse experience data shall be forwarded by facsimile or courier as quickly as may be necessary to permit the recipient to comply with any applicable legal requirements and in no event later than the earlier of 7 calendar days after such data is prepared or acquired and the date such data is provided to any Regulatory Authority. As used herein, the phrase "ADVERSE EXPERIENCE DATA" shall mean all data concerning any serious or unexpected adverse effects, sideeffects and contraindications of any Product that come to the attention of either Party, its Affiliates or sublicensees and of such a nature and magnitude that it is required under the laws of the country to be collected, maintained and reported to the appropriate Regulatory Authority.
Other Information and Data. Each Party shall provide to the other Party complete and accurate copies of all documentation containing Supporting Data, Clinical Study Reports or other Study Reports, and other data relating to the Licensed Products, which is prepared or acquired by such Party or any of its respective Sublicensees during the term of this Agreement.
Other Information and Data. Millennium shall also provide Portola with additional material information and data that is necessary or useful for Regulatory Approval or commercialization of Products and that is referenced or summarized in any of the items transferred to Portola pursuant to Section 4.3 for the Products but that is not otherwise transferred to Portola pursuant to this Article
Other Information and Data. Each party shall provide to the other party complete and accurate copies of all documentation containing Supporting Data, Adverse Experience Data (as defined below) and other data relating to the Licensed Products, which is prepared or acquired by such party or any of its respective sublicensees during the term of this Agreement. Copies of Supporting Data shall be forwarded by first class mail or faster means of transmission within thirty (30) days after it shall have been prepared or acquired. Copies of Adverse Experience Data shall be forwarded by facsimile or courier as quickly as may be necessary to